News NHS cuts clinical trial bureaucracy NHS chiefs have introduced new arrangements to fast track clinical trials and improve patients’ access to cutting-edge therapies.
News Roche cancer guru quits to lead 'off-the-shelf' T-cell R&D a... San Francisco biotech developing therapy for post-transplant blood disorder
News NICE asks EUSA pharma to drop price of neuroblastoma drug NICE calls for price cut before possible CDF funding
News BMS strikes three-year cancer R&D deal with Flatiron Bristol-Myers Squibb has struck a three-year with Flatiron Health that aims to make cancer R&D more efficient and patient-focused.
News J&J could pay $1 billion for oncolytic virus firm BeneVir J&J follows Merck & Co, and BMS with oncolytic virus acquisition
News Novartis matches Gilead on price in new CAR-T use Novartis won't offer 'money back' scheme because of delayed effect
News UK's Levicept builds case for osteoarthritis therapy at ACR New data on Levicept's LEVI-04 in patients with osteoarthritis support its potential to become the first new systemic treatment in over two decades.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.
